208 related articles for article (PubMed ID: 7689443)
1. Impact of the fluoroquinolones on gastrointestinal flora.
Korten V; Murray BE
Drugs; 1993; 45 Suppl 3():125-33. PubMed ID: 7689443
[TBL] [Abstract][Full Text] [Related]
2. Impact of fluoroquinolones on the gastrointestinal flora.
Murray BE
Rev Infect Dis; 1989; 11 Suppl 5():S1372-8. PubMed ID: 2672259
[TBL] [Abstract][Full Text] [Related]
3. The effect of quinolone antibacterials on the gastrointestinal flora compared with that of other antibacterials.
Reeves DS
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():89-102. PubMed ID: 3542950
[TBL] [Abstract][Full Text] [Related]
4. Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora.
Richard P; Delangle MH; Raffi F; Espaze E; Richet H
Clin Infect Dis; 2001 Jan; 32(1):162-6. PubMed ID: 11112677
[TBL] [Abstract][Full Text] [Related]
5. Effect of new quinolones on the human gastrointestinal microflora.
Nord CE
Rev Infect Dis; 1988; 10 Suppl 1():S193-6. PubMed ID: 3279492
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of Y-688, a new 7-substituted fluoroquinolone, against anaerobic bacteria.
MacGowan AP; Bowker KE; Wootton M; Holt HA; Reeves DS
Antimicrob Agents Chemother; 1998 Feb; 42(2):419-24. PubMed ID: 9527797
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects.
Gootz TD; Brighty KE
Med Res Rev; 1996 Sep; 16(5):433-86. PubMed ID: 8865150
[No Abstract] [Full Text] [Related]
8. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
[TBL] [Abstract][Full Text] [Related]
9. [In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study].
Soussy CJ; Le Van Thoi J; Morel C; Acar JF; Thabaut A; Fleurette J; Vallée E; Dabernat H; Chanal M; Drugeon H
Pathol Biol (Paris); 1990 May; 38(5):390-6. PubMed ID: 2195448
[TBL] [Abstract][Full Text] [Related]
10. [In vitro activity of trovafloxacin (CP-99,219) against 434 bacterial strains: comparative study with other fluoroquinolones].
Tali-Maamar H; Tebbal S; Rahal K
Arch Inst Pasteur Alger; 1998; 62():52-61. PubMed ID: 11256319
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
12. Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Haas W; Pillar CM; Zurenko GE; Lee JC; Brunner LS; Morris TW
Antimicrob Agents Chemother; 2009 Aug; 53(8):3552-60. PubMed ID: 19506065
[TBL] [Abstract][Full Text] [Related]
13. Comparative bactericidal activity of fluoroquinolones against clinical isolates resistant to fluoroquinolones.
Drago L; De Vecchi E; Nicola L; Valli M; Marchetti F; Gismondo MR
J Chemother; 2003 Apr; 15(2):118-23. PubMed ID: 12797386
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolones.
O'Donnell JA; Gelone SP
Infect Dis Clin North Am; 2000 Jun; 14(2):489-513, xi. PubMed ID: 10829268
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.
Jones RN; Pfaller MA
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323
[TBL] [Abstract][Full Text] [Related]
16. Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents.
Neu HC
Drugs; 1993; 45 Suppl 3():54-8. PubMed ID: 7689452
[TBL] [Abstract][Full Text] [Related]
17. [Moxifloxacin--antimicrobial activity and pharmacokinetic properties].
Iakovlev VP; Polushkina NR
Antibiot Khimioter; 2002; 47(5):19-29. PubMed ID: 12365324
[No Abstract] [Full Text] [Related]
18. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
Moros M; Coll R; Esteve M; Parés J; Xicota MA
Chemioterapia; 1987 Jun; 6(2 Suppl):149-51. PubMed ID: 3509373
[No Abstract] [Full Text] [Related]
19. Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers.
Leigh DA; Harris C; Tait S; Walsh B; Hancock P
J Antimicrob Chemother; 1991 May; 27(5):655-62. PubMed ID: 1885423
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE
Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
